Sp334
MICROBIALLY DERIVED PROTEASES FOR THE TREATMENT OF CELIAC DISEASE
Date
May 18, 2024
Presenter
Tracks
Related Products
Advancing-microbially Based Therapies for Celiac Disease and Other Food Sensitivities
SOCIETY: AGA Genes and dietary gluten are necessary, but insufficient, to develop celiac disease, a common autoimmune enteropathy with systemic manifestations and co-morbid associations. Microbes, in the form of infections and perturbations of the gut microbiome, have emerged as key cofactors…
CALY-002, AN ANTI-IL-15 ANTIBODY, PREVENTS GLUTEN CHALLENGE-INDUCED MUCOSAL DAMAGE AND INFLAMMATION: RESULTS FROM A PHASE 1A/B STUDY
Interleukin-15 (IL-15) is a cytokine involved in tissue homeostasis and inflammation, and a potent regulator of innate and adaptive immune responses. IL-15 expression has been shown to be dysregulated in celiac disease (CeD)…
CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…
